Any feedback?
Please rate this page
(search_result.php)
(0/150)

BRENDA support

Refine search

Search Disease/ Diagnostics

show results
Refine your search

Search term:

Results 1 - 10 of 27745 > >>
EC Number Disease PubMed ID Title of Publication Category Confidence Level
Show all pathways known for 1.14.99.1Display the word mapDisplay the reaction diagram Show all sequences 1.14.99.111beta-hydroxysteroid dehydrogenase deficiency 15718388 Interactions between 11beta-hydroxysteroid dehydrogenase and COX-2 in kidney. causal interaction
ongoing research
unassigned
4
4
0
Show all pathways known for 1.14.99.1Display the word mapDisplay the reaction diagram Show all sequences 1.14.99.1Aberrant Crypt Foci 8601574 Suppression of azoxymethane-induced aberrant crypt foci in rat colon by nimesulide, a selective inhibitor of cyclooxygenase 2. causal interaction
therapeutic application
unassigned
3
4
0
Show all pathways known for 1.14.99.1Display the word mapDisplay the reaction diagram Show all sequences 1.14.99.1Aberrant Crypt Foci 8840961 Evaluation of cyclooxygenase-2 inhibitor for potential chemopreventive properties in colon carcinogenesis. causal interaction
ongoing research
therapeutic application
unassigned
4
1
4
0
Show all pathways known for 1.14.99.1Display the word mapDisplay the reaction diagram Show all sequences 1.14.99.1Aberrant Crypt Foci 9439679 Inhibitory effect of NS-398, a selective cyclooxygenase-2 inhibitor, on azoxymethane-induced aberrant crypt foci in colon carcinogenesis of F344 rats. causal interaction
ongoing research
therapeutic application
unassigned
4
4
4
0
Show all pathways known for 1.14.99.1Display the word mapDisplay the reaction diagram Show all sequences 1.14.99.1Aberrant Crypt Foci 9458081 Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, against colon carcinogenesis. causal interaction
therapeutic application
unassigned
4
4
0
Show all pathways known for 1.14.99.1Display the word mapDisplay the reaction diagram Show all sequences 1.14.99.1Aberrant Crypt Foci 11216473 COX-2 and iNOS, good targets for chemoprevention of colon cancer. causal interaction
ongoing research
therapeutic application
unassigned
4
3
4
0
Show all pathways known for 1.14.99.1Display the word mapDisplay the reaction diagram Show all sequences 1.14.99.1Aberrant Crypt Foci 11280748 Modulation of experimental colon tumorigenesis by types and amounts of dietary fatty acids. causal interaction
diagnostic usage
ongoing research
therapeutic application
4
3
3
1
Show all pathways known for 1.14.99.1Display the word mapDisplay the reaction diagram Show all sequences 1.14.99.1Aberrant Crypt Foci 11782374 Chemopreventive properties of a selective inducible nitric oxide synthase inhibitor in colon carcinogenesis, administered alone or in combination with celecoxib, a selective cyclooxygenase-2 inhibitor. causal interaction
diagnostic usage
therapeutic application
unassigned
4
3
4
0
Show all pathways known for 1.14.99.1Display the word mapDisplay the reaction diagram Show all sequences 1.14.99.1Aberrant Crypt Foci 14583451 Energy restriction reduces the number of advanced aberrant crypt foci and attenuates the expression of colonic transforming growth factor beta and cyclooxygenase isoforms in Zucker obese (fa/fa) rats. causal interaction
diagnostic usage
ongoing research
unassigned
1
4
1
0
Show all pathways known for 1.14.99.1Display the word mapDisplay the reaction diagram Show all sequences 1.14.99.1Aberrant Crypt Foci 14643021 Chemopreventive effect of JTE-522, a selective cyclooxygenase-2 inhibitor, on 1, 2-dimethylhydrazine-induced rat colon carcinogenesis. causal interaction
ongoing research
therapeutic application
unassigned
4
2
4
0
Results 1 - 10 of 27745 > >>